SI

SIEMENS AKTIENGESELLSCHAFT ADS

SI

Overview Fund Activity

Delisted

SI was delisted on the 15th of May, 2014.

Back to rankings

Industrials Specialty Industrial Machinery

Financial journalist opinion

Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025

Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day GRAND RAPIDS, Mich. , Aug. 28, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2025 before market open on Tuesday, September 9, 2025.

Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025

Shoulder Innovations: Interesting, Not Convinced

Shoulder Innovations IPO priced below range, reflecting investor caution as revenue growth slows sharply despite strong prior expansion. Valuation is modest at 3-4x sales, supported by a substantial net cash position, but ongoing operating losses remain a concern. Key risks include product concentration, regulatory challenges, and fierce competition from established medtech giants like J&J and Stryker.

Shoulder Innovations: Interesting, Not Convinced

U.S. IPO Weekly Recap: 6 Small Listings Hit Market As Sizable IPOs Join The Pipeline

Six IPOs and one SPAC debuted this week. Nine IPOs and two SPACs submitted initial filings this week. Two sizable mining companies are slated to go public in the US in the week ahead.

U.S. IPO Weekly Recap: 6 Small Listings Hit Market As Sizable IPOs Join The Pipeline

Shoulder Innovations Begins IPO Effort For Commercialization Plans

Shoulder Innovations, Inc. has filed to raise $100 million in a U.S. IPO. The company is targeting the shoulder arthroplasty market, leveraging proprietary technology and a specialized commercial team, but faces intense competition and potential scaling risks. IPO proceeds will fund commercial expansion, R&D, and working capital, with management expecting funds to last at least 12 months post-offering.

Shoulder Innovations Begins IPO Effort For Commercialization Plans

WorkForce Software Announces Partner Excellence Award Winners: Accenture, EPI-USE, Intelligenza IT, and SAP SuccessFactors, as Growing Demand for Workforce Management Technology and Global Expansion Continue in 2024

LIVONIA, Mich.--(BUSINESS WIRE)--WorkForce Software, a workforce management solution for large employers, announces the winners of its Partner Excellence Awards at VISION 2024.

WorkForce Software Announces Partner Excellence Award Winners: Accenture, EPI-USE, Intelligenza IT, and SAP SuccessFactors, as Growing Demand for Workforce Management Technology and Global Expansion Continue in 2024

See News Rankings

Charts implemented using Lightweight Charts™